Multidisciplinary re-evaluation of neuropsychiatric events to confirm the neuropsychiatric lupus diagnosis at an Indonesian tertiary hospital

Estiasari,R.,Banu,S.,Widhani,A.,Octaviana,F.,Maharani,K.,Aninditha,T.,Islami,M. H.,Imran,D.,Lastri,D. N.
DOI: https://doi.org/10.1136/lupus-2024-001163
IF: 4.687
2024-06-09
Lupus Science & Medicine
Abstract:Objective Neuropsychiatric SLE (NPSLE) has a broad spectrum and to date, there is no gold-standard biomarker. The diagnosis relies on clinical assessment, supporting examinations and exclusion of other possible aetiologies. One method that can be used to establish NPSLE is to conduct a re-evaluation by involving several fields of medical science. This study aims to reassess SLE cases with neuropsychiatric (NP) manifestations through multidisciplinary re-evaluation and determine the final diagnosis of NPSLE or non-NPSLE. Methods This retrospective cross-sectional study used medical record data from patients with SLE with NP manifestations. Inclusion criteria included patients diagnosed with SLE, who had clinical manifestations of NP and were >18 years old. Multidisciplinary re-evaluation was conducted and agreed upon the diagnosis of NPSLE or non-NPSLE. Results We included 94 subjects with a total of 132 NP events consisting of 69 NPSLE and 63 non-NPSLE. After re-evaluating NPSLE events, 33.3% were still concluded to be NPSLE. Meanwhile, from the non-NPSLE group, 22.2% were then declared as NPSLE. There were no significant differences in demographic characteristics between the NPSLE and non-NPSLE groups. The proportion of NP events in both groups was almost the same except for cerebrovascular disease manifestations which were more common in the NPSLE group. Higher Mexican SLE Disease Activity Index scores with (p<0.001) or without NP (p=0.02) were observed in the NPSLE group compared with the non-NPSLE group, as well as higher proportion of active disease (p=0.03), higher anti-double-stranded DNA titres (p<0.001) and lower values of C3 (p=0.018) and C4 (p=0.001). Conclusions Multidisciplinary re-evaluation can be used as a method to confirm the diagnosis of NPSLE. There is a tendency for overdiagnosis of NPSLE when clinicians are faced with NP events in patients with SLE. Complete clinical and supporting data are needed to determine the final diagnosis of NPSLE.
rheumatology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the accuracy of the diagnosis of neuropsychiatric symptoms (NPSLE) in patients with systemic lupus erythematosus (SLE). Specifically, the paper aims to confirm or exclude the diagnosis of NPSLE through multidisciplinary re - evaluation and explore the differences in clinical and laboratory characteristics between NPSLE and non - NPSLE. The following are the main research objectives of the paper: 1. **Re - evaluate the NPSLE diagnosis**: Through the re - evaluation of a multidisciplinary team, confirm which neuropsychiatric events are actually caused by SLE (NPSLE) and which are caused by other reasons (non - NPSLE). 2. **Diagnostic consistency**: Evaluate the consistency between the initial diagnosis and the diagnosis after re - evaluation to determine whether there are cases of over - diagnosis or missed diagnosis. 3. **Comparison of clinical and laboratory characteristics**: Compare the differences in clinical manifestations, laboratory test results, etc. between NPSLE and non - NPSLE patients to find possible diagnostic markers. ### Main findings 1. **Diagnostic changes**: - Of the 69 events initially diagnosed as NPSLE, only 23 (33.3%) were still diagnosed as NPSLE after re - evaluation. - Of the 63 events initially diagnosed as non - NPSLE, 14 (22.2%) were diagnosed as NPSLE after re - evaluation. 2. **Clinical characteristics**: - The MEX - SLEDAI score in the NPSLE group was significantly higher than that in the non - NPSLE group, both when there were neuropsychiatric symptoms and when there were no neuropsychiatric symptoms. - The proportion of active SLE in the NPSLE group was significantly higher than that in the non - NPSLE group. - The titer of anti - double - stranded DNA antibody in the NPSLE group was significantly higher than that in the non - NPSLE group, while the levels of C3 and C4 were significantly lower than those in the non - NPSLE group. 3. **Imaging and lumbar puncture results**: - The results of brain MRI and CT scans showed that the proportion of abnormalities in the NPSLE group was higher. - The results of lumbar puncture showed that the cerebrospinal fluid glucose level in the non - NPSLE group was lower. ### Conclusion Multidisciplinary re - evaluation can be used as an effective method to confirm the diagnosis of NPSLE. The study found that there is a trend of over - diagnosis of NPSLE in clinical practice, so complete clinical and auxiliary data are required to determine the final diagnosis. This emphasizes the importance of multidisciplinary teams in the diagnosis of NPSLE, which helps to improve the accuracy of diagnosis and reduce misdiagnosis.